Abstract:Involved‐field high‐dose (≥ 66 Gy) chemoradiotherapy with respiratory motion management for esophageal squamous cell carcinoma resulted in a 2‐year overall survival rate of 51.4% and a low total failure rate of 45.7%, with only 2.9% exhibiting out‐of‐field regional nodal failure. However, esophageal fistulas, associated with bronchial/tracheal tumor compression and higher doses (70 Gy), significantly worsened survival outcomes. Evaluating fistula risk is crucial for dose escalation feasibility. Background We investigated the clinical outcomes of involved‐field high‐dose (≥66 Gy) chemoradiotherapy (CRT) combined with respiratory motion management for esophageal squamous cell carcinoma (ESCC). Methods Patients who underwent definitive CRT for histologically confirmed ESCC in our department between 2012 and 2018 were retrospectively analyzed. Respiratory motion management strategies included breath‐holding (63%) and mask immobilization (29%) based on individual measurements of respiratory tumor motion using radiographic fluoroscopy with endoscopically placed clip markers as landmarks. We evaluated patient characteristics, treatment efficacy, failure patterns, and toxicities. Results We enrolled 35 patients with a prescribed dose of 66–70 Gy in 33–35 fractions. The overall response rate within 6 months post‐CRT was 94.3%; the median follow‐up period for survivors was 43 months. The 2‐year overall survival (OS), progression‐free survival, and locoregional failure‐free survival rates were 51.4%, 42.9%, and 42.9%, respectively. A significant difference in OS was observed between patients with and without esophageal fistulas after CRT (p = 0.002, log‐rank test). Disease failure occurred in 16 patients (45.7%), including one (2.9%) with out‐of‐field regional nodal failure. Major grade 3 or higher toxicities included decreased white blood cell count (48.6%), neutrophil count (34.3%), and esophageal stenosis (31.4%). No grade 3 or higher cardiopulmonary toxicities were observed. Bronchial/tracheal tumor compression and a higher radiotherapy dose (70 Gy) were significantly correlated with esophageal fistulas. Conclusion Involved‐field high‐dose CRT with respiratory motion management may be a feasible treatment option for ESCC. However, a comprehensive assessment of esophageal fistula risk is required to identify suitable candidates.

Acute Exacerbation of Tracheal Obstruction and Severe Respiratory Failure after a Single Dose of 2-Gy Irradiation for Squamous Cell Lung Carcinoma: A Case Report

Emergency Management of A Patient with Severe Airway Obstruction Resulting from Poorly Differentiated Thyroid Carcinoma: A Case Report

Airway Edema after Keloid Resection and Superficial Radiation: Unexpected Event in an Unusual Location

Hyperacute Radiation Pneumonitis after Severe irAE

[A case of radiation pneumonitis caused by treatment of lung cancer which revealed marked hypervasculality on bronchial arteriography]

Involved‐field high‐dose chemoradiotherapy with respiratory motion management for esophageal squamous cell carcinoma

Bystander Effect and Abscopal Effect in Recurrent Thymic Carcinoma Treated with Carbon-Ion Radiation Therapy: A Case Report

Emergency stent implantation for acute dyspnea caused by severe tracheal stenosis

Combining Therapy of Octreotide and Glucocorticoid in the Treatment of a Lung Adenocarcinoma Patient with Acute Respiratory Distress Syndrome

Bronchiolitis obliterans organizing pneumonia after stereotactic ablative radiation therapy for lung cancer: A case report

A Case of Lung Squamous Cell Carcinoma Retroperitoneal Lymph Node Metastasis Whose Lymphedema Was Improved by Radiation Therapy and Was Temporarily Discharged from the Hospital

Tracheal injury diagnosed by a sudden increase in end-tidal carbon dioxide levels during mediastinoscopic subtotal esophagectomy: a case report

Long-term survival after definitive proton beam therapy for oligorecurrent esophageal squamous cell carcinoma: a case report

High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma

A case of tracheobronchial amyloidosis treated with endoscopic debulking and external beam radiation therapy

Successful management of postoperative tracheal metastasis in small cell lung cancer with radiotherapy and durvalumab: A case report

[A case report of the laryngeal edema and peripheral cyanosis after extubation of the tracheal tube]

Dose-Escalated Radiotherapy for Primary Tracheobronchial Adenoid Cystic Carcinoma

Oncological Outcomes of Concurrent Chemoradiotherapy and Surgical Treatment for Patients With T3 Hypopharyngeal Cancer: A Single-Center Retrospective Analysis

Risk Factors for Acute Esophagitis in Non–small-Cell Lung Cancer Patients Treated with Concurrent Chemotherapy and Three-Dimensional Conformal Radiotherapy

Treatment-related pneumonitis after thoracic radiotherapy/chemoradiotherapy combined with anti-PD-1 monoclonal antibodies in advanced esophageal squamous cell carcinoma